参考文献/References:
[1] 刘丽,武愫斌.双氧化酶成熟因子2基因检测在肺癌患者淋巴结转移及预后预测中的价值研究[J].陕西医学杂志,2022,51(8):1029-1032.
[2] MANTOVANI A,ALLAVENA P,SICA A,et al.Cancer related inflammation[J].Nature,2008,454:436-444.
[3] 张栓宝,严宁娟,张燕平.复方斑蝥胶囊对非小细胞肺癌患者围术期血清炎症因子及免疫功能的影响[J].陕西中医,2019,40(7):890-892.
[4] BALKWILL F,MANTOVANI A.Inflammation and cancer:Back to Virchow?[J].Lancet,2001,357:539-545.
[5] KALEMKERIAN G P,LOO B W,AKERLEY W,et al.NCCN guidelines insights:Small cell lung cancer,version 2.2018[J].J Natl Compr Canc Netw,2018,16(10):1171-1182.
[6] YUAN Y,ZHONG H,YE L,et al.Prognostic value of pretreatment platelet counts in lung cancer:A systematic review and meta-analysis[J].BMC Pulmonary Medicine,2020,20(1):1-11.
[7] ELLINGSEN T S,LAPPEGARD J,SKJELBAKKEN T,et al.Impact of red cell distribution width on future risk of cancer and allcause mortality among cancer patients-the Tromsø Study[J].Haematologica,2015,100(10):e387-e389.
[8] XU W Y,YANG X B,WANG W Q,et al.Prognostic impact of the red cell distribution width in esophageal cancer patients:A systematic review and meta-analysis[J].World J Gastroenterol,2018,24(19):2120-2129.
[9] YAZICI P,DEMIR U,BOZKURT E,et al.The role of red cell distribution width in the prognosis of patients with gastric cancer[J].Cancer Biomarkers,2017,18(1):19-25.
[10] KOMA Y,ONISHI A,MATSUOKA H,et al.Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer[J].PLoS One,2013,8(11):e80240.
[11] LIPPI G,PLEBANI M.Red blood cell distribution width(RDW)and human pathology.One size fits all[J].Clin Chem Lab Med,2014,52(9):1247-1249.
[12] ARGILES J M.Cancer-associated malnutrition[J].Eur J Oncol Nurs,2005,9(2):s39-s50.
[13] MONTAGNANA M,DANESE E.Red cell distribution width and cancer[J].Ann Transl Med,2016,4(20):399.
[14] 刘海涛,衣秀秀,田建辉.肺癌中西医抗凝治疗研究进展[J].陕西中医,2020,41(1):127-130.
[15] LEE Y,KIM S H,HAN J Y,et al.Early neutrophil-to lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy[J].J Cancer Res Clin Oncol,2012,138:2009-2016.
[16] PETRIE H T,KLASSEN L W,KAY H D.Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes[J].J Immunol,1985,134:230-234.
[17] OHASHI R,TAKAHASHI K,MIURA K,et al.Prognostic factors in patients with inoperable non-small cell lung cancer-an analysis of long-term survival patients[J].Gan To Kagaku Ryoho,2006,33(11):1595-1602.
[18] CONDEELIS J,POLLARD J W.Macrophages:Obligate partners for tumor cell migration,invasion,and metastasis[J].Cell,2006,124(2):263-266.
[19] 周晓云,王琛,顾若琪,等.白蛋白、D-二聚体、中性粒细胞、血小板淋巴细胞比值及血小板计数对社区获得性肺炎严重程度的诊断价值[J].陕西医学杂志,2024,53(1):104-108.
[20] GOUBRAN H A,BURNOUF T,RADOSEVIC M,et al.The platelet-cancer loop[J].Eur J Intern Med,2013,24:393-400.
[21] 李君艳,陈国荣.肺癌患者凝血指标与临床特征的关系[J].陕西医学杂志,2019,48(6):718-721.
[22] 任东峰,孙国芳.六君祛痰解毒汤联合化疗治疗非小细胞肺癌疗效及对患者血管内皮生长因子的影响[J].陕西中医,2020,41(1):63-65.
[23] BENOY I,SALGADO R,COLPAERT C,et al.Serum interleukin 6,plasma VEGF,serum VEGF,and VEGF platelet load in breast cancer patients[J].Clin Breast Cancer,2002,2(4):311-315.
[24] WIESNER T,BUGL S,MAYER F,et al.Differential changes in platelet VEGF,Tsp,CXCL12,and CXCL4 in patients with metastatic cancer[J].Clin Exp Metastasis,2010,27(3):141-149.
[25] BAMBACE N M,HOLMES C E.The platelet contribution to cancer progression[J].Thromb Haemost,2011,9(2):237-249.
[26] 雷鸣,杨丽,胡太华,等.非小细胞肺癌远处转移与血小板参数变化的相关性分析[J].国际检验医学杂志,2015,36(6):729-730.
[27] MANGALPALLY K K,SIQUEIROS-GARCIA A,VADUGANATHAN M.Platelet activation patterns in plateletsize sub-populations:Differential responses to aspirin in vitro[J].J Thromb Thrombolysis,2010,30(3):251-262.
[28] 刘玲佩.肺癌患者血小板的检测及相关性研究[J].亚太传统医药,2011,7(7):92-93.
相似文献/References:
[1]贾丽娟,杜苏丰.重组新城疫病毒疫苗rlRVG对A549荷瘤小鼠瘤体生长的抑制作用[J].陕西医学杂志,2019,(1):6.
JIA Lijuan,DU Sufeng..The tumor growth influence of recombinant NDV (rlRVG) on lung adenocarcinoma A549transfected in vivo[J].,2019,(8):6.
[2]江茂琼,贾钰铭△,叶文静,等.MDSCs对肺癌小鼠CD8+T细胞及生存期的影响研究[J].陕西医学杂志,2019,(3):293.
JIANG Maoqiong,JIA Yuming,LI Ting,et al.Effect of MDSCs on CD8 T cells and survival time of lung cancer mice[J].,2019,(8):293.
[3]李君艳,陈国荣.肺癌患者凝血指标与临床特征的关系*[J].陕西医学杂志,2019,(6):718.
LI Junyan,CHEN Guorong..The relationships between coagulation indicators and clinic characterisitics of patients with lung cancer[J].,2019,(8):718.
[4]王 玲,申 鸿.癌胚抗原、糖类抗原、CA125、血管生成素、细胞角蛋白19片段及甲胎蛋白检测在肺癌诊断中的临床研究*[J].陕西医学杂志,2019,(8):1080.
WANG Ling,SHEN Hong..The value of tumor markers CEA,CA199,CA125,Ang-2,CYFRA211 and AFP in the diagnosis of lung cancer[J].,2019,(8):1080.
[5]韩 乐,陈文娟△,雷光焰,等.microRNA21、microRNA25在肺癌组织中的表达及意义*[J].陕西医学杂志,2019,(12):1596.
HAN Le,CHEN Wenjuan,LEI Guangyan,et al.Expression and significance of microRNA21 and microRNA25 in lung cancer tissues[J].,2019,(8):1596.
[6]王 勇,张 勇,白正忠△.单操作孔完全胸腔镜与传统三孔胸腔镜治疗老年肺癌疗效对比研究*[J].陕西医学杂志,2019,(12):1670.
[7]刘 静.红细胞分布宽度联合降钙素原检测对急性胰腺炎严重程度及预后评估价值分析[J].陕西医学杂志,2020,49(4):470.
LIU Jing..Value of Red cell distribution width combined with procalcitonin in evaluating the severity and prognosis of acute pancreatitis[J].,2020,49(8):470.
[8]尹 梅.喘息性支气管炎患儿红细胞分布宽度与其预后相关性研究[J].陕西医学杂志,2020,49(7):841.[doi:DOI:10.3969/j.issn.10007377.2020.07.020]
YIN Mei..Correlation between red cell distribution width and prognosis in children with asthmatic bronchitis[J].,2020,49(8):841.[doi:DOI:10.3969/j.issn.10007377.2020.07.020]
[9]常瑞霞,可春梅.血小板相关参数和凝血指标在肺癌治疗中的变化及意义[J].陕西医学杂志,2021,50(5):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
CHANG Ruixia,KE Chunmei.Changes and significance of platelet-related parameters and coagulation indexes in treatment of lung cancer[J].,2021,50(8):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
[10]柳 林,金 钧,黄 芳,等.凝血酶-抗凝血酶复合物与红细胞分布宽度检测在急性胰腺炎严重程度及预后评估中的价值[J].陕西医学杂志,2021,50(6):742.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.026]
LIU Lin,JIN Jun,HUANG Fang,et al.Role of TAT and RDW in evaluation of the severity and prognosis of acute pancreatitis[J].,2021,50(8):742.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.026]